Sectors & IndustriesHealthcareMedical Instruments & Supplies

Best Medical Stocks to Buy Now (2025)

Top medical stocks in 2025 ranked by overall Due Diligence Score. See the best medical stocks to buy now, according to analyst forecasts for the medical instruments & supplies industry.

According to Due Diligence Score, the 3 best medical stocks to buy right now are:

Hologic (NASDAQ:HOLX) is the top medical stock with a Due Diligence Score of 58, which is 30 points higher than the medical industry average of 28. It passed 18 out of 33 due diligence checks and has strong fundamentals. Hologic has seen its stock lose -11.91% over the past year, underperforming other medical stocks by -12 percentage points.

Hologic has an average 1 year price target of $85.00, an upside of 30.29% from Hologic's current stock price of $65.24.

Hologic stock has a consensus Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Hologic, 16.67% have issued a Strong Buy rating, 16.67% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Resmed (NYSE:RMD) is the second best medical stock with a Due Diligence Score of 58, which is 30 points higher than the medical industry average of 28. It passed 22 out of 38 due diligence checks and has strong fundamentals. Resmed has seen its stock return 30.7% over the past year, overperforming other medical stocks by 30 percentage points.

Resmed has an average 1 year price target of $253.00, an upside of 6.05% from Resmed's current stock price of $238.56.

Resmed stock has a consensus Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Resmed, 33.33% have issued a Strong Buy rating, 11.11% have issued a Buy, 44.44% have issued a hold, while 11.11% have issued a Sell rating, and 0% have issued a Strong Sell.

Becton Dickinson & Co (NYSE:BDX) is the third best medical stock with a Due Diligence Score of 52, which is 24 points higher than the medical industry average of 28. It passed 19 out of 38 due diligence checks and has strong fundamentals. Becton Dickinson & Co has seen its stock lose -5.68% over the past year, underperforming other medical stocks by -6 percentage points.

Becton Dickinson & Co has an average 1 year price target of $281.67, an upside of 22.7% from Becton Dickinson & Co's current stock price of $229.55.

Becton Dickinson & Co stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Becton Dickinson & Co, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 9 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

Baxter International (NYSE:BAX) has an annual dividend yield of 2.43%, which is 1 percentage points higher than the medical industry average of 1.28%. Baxter International's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Baxter International's dividend has not shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of 552.4% indicates that its dividend yield might not be sustainable for the long-term.

Utah Medical Products (NASDAQ:UTMD) has an annual dividend yield of 1.99%, which is 1 percentage points higher than the medical industry average of 1.28%. Utah Medical Products's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Utah Medical Products's dividend has shown consistent growth over the last 10 years.

Utah Medical Products's dividend payout ratio of 28.1% indicates that its dividend yield is sustainable for the long-term.

Becton Dickinson & Co (NYSE:BDX) has an annual dividend yield of 1.69%, which is the same as the medical industry average of 1.28%. Becton Dickinson & Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Becton Dickinson & Co's dividend has shown consistent growth over the last 10 years.

Becton Dickinson & Co's dividend payout ratio of 65.3% indicates that its dividend yield is sustainable for the long-term.

Medical stocks were up 0.59% in the last day, and down -1.74% over the last week.

We couldn't find a catalyst for why medical stocks are up.

Based on WallStreetZen's Valuation Score, the 3 most undervalued medical stocks right now are:

Embecta (NASDAQ:EMBC) is the most undervalued medical stock based on WallStreetZen's Valuation Score. Embecta has a valuation score of 86, which is 67 points higher than the medical industry average of 19. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has gained 16.87% in the past year. It has overperformed other stocks in the medical industry by 16 percentage points.

Utah Medical Products (NASDAQ:UTMD) is the second most undervalued medical stock based on WallStreetZen's Valuation Score. Utah Medical Products has a valuation score of 71, which is 52 points higher than the medical industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Utah Medical Products's stock has dropped -19.43% in the past year. It has underperformed other stocks in the medical industry by -20 percentage points.

Hologic (NASDAQ:HOLX) is the third most undervalued medical stock based on WallStreetZen's Valuation Score. Hologic has a valuation score of 71, which is 52 points higher than the medical industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Hologic's stock has dropped -11.91% in the past year. It has underperformed other stocks in the medical industry by -12 percentage points.